Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Eckmann

Showing results (41-50 of 76) with videos related to

Pageof 8
Sort By:
Current Opinion in Infectious Diseases|December 12, 2023
Left ventricular assist device-associated driveline infections as a specific form of complicated skin and soft tissue infection/acute bacterial skin and skin structure infection - issues and therapeutic optionsChristian Eckmann, Cord Sunderkötter, Karsten Becker, et al.
Chemotherapy|October 12, 2012
Therapy of 1,025 severely ill patients with complicated infections in a German multicenter study: safety profile and efficacy of tigecycline in different treatment modalitiesKlaus-Friedrich Bodmann, Wolfgang R Heizmann, Christof von Eiff, et al.
Antimicrobial Resistance and Infection Control|January 1, 2020
Cost-effectiveness analysis comparing ceftazidime/avibactam (CAZ-AVI) as empirical treatment comparing to ceftolozane/tazobactam and to meropenem for complicated intra-abdominal infection (cIAI)Thitima Kongnakorn, Christian Eckmann, Matteo Bassetti, et al.
Surgical Infections|March 17, 2016
Evaluation of Tigecycline Efficacy and Post-Discharge Outcomes in a Clinical Practice Population with Complicated Intra-Abdominal Infection: A Propensity Score-Matched AnalysisJoseph Solomkin, C Daniel Mullins, Alvaro Quintana, et al.
Clinical Therapeutics|November 22, 2016
Value of Propensity Score Matching for Equalizing Comparator Groups in Observational Database Studies: A Case Study in Anti-infectivesC Daniel Mullins, Frank R Ernst, Michelle R Krukas, et al.
American Journal of Surgery|February 3, 2009
Fournier's gangrene: vacuum-assisted closure versus conventional dressingsRalf Czymek, Andreas Schmidt, Christian Eckmann, et al.
Deutsche Medizinische Wochenschrift (1946)|June 27, 2015
[Current strategies against multi-drug resistant organisms]Mathias W Pletz, Christian Eckmann, Stefan Hagel, et al.
European Journal of Internal Medicine|July 30, 2024
Intra-abdominal infection and sepsis in immunocompromised intensive care unit patients: Disease expression, microbial aetiology, and clinical outcomesJosé-Artur Paiva, Jordi Rello, Christian Eckmann, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 12, 2015
Ceftolozane/Tazobactam Plus Metronidazole for Complicated Intra-abdominal Infections in an Era of Multidrug Resistance: Results From a Randomized, Double-Blind, Phase 3 Trial (ASPECT-cIAI)Joseph Solomkin, Ellie Hershberger, Benjamin Miller, et al.
Plos One|December 28, 2022
Clinical and economic burden of surgical site infections in inpatient care in Germany: A retrospective, cross-sectional analysis from 79 hospitalsChristian Eckmann, Axel Kramer, Ojan Assadian, et al.
Pageof 8

Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
Current Opinion in Infectious Diseases|December 12, 2023
Left ventricular assist device-associated driveline infections as a specific form of complicated skin and soft tissue infection/acute bacterial skin and skin structure infection - issues and therapeutic optionsChristian Eckmann, Cord Sunderkötter, Karsten Becker, et al.
Chemotherapy|October 12, 2012
Therapy of 1,025 severely ill patients with complicated infections in a German multicenter study: safety profile and efficacy of tigecycline in different treatment modalitiesKlaus-Friedrich Bodmann, Wolfgang R Heizmann, Christof von Eiff, et al.
Antimicrobial Resistance and Infection Control|January 1, 2020
Cost-effectiveness analysis comparing ceftazidime/avibactam (CAZ-AVI) as empirical treatment comparing to ceftolozane/tazobactam and to meropenem for complicated intra-abdominal infection (cIAI)Thitima Kongnakorn, Christian Eckmann, Matteo Bassetti, et al.
Surgical Infections|March 17, 2016
Evaluation of Tigecycline Efficacy and Post-Discharge Outcomes in a Clinical Practice Population with Complicated Intra-Abdominal Infection: A Propensity Score-Matched AnalysisJoseph Solomkin, C Daniel Mullins, Alvaro Quintana, et al.
Clinical Therapeutics|November 22, 2016
Value of Propensity Score Matching for Equalizing Comparator Groups in Observational Database Studies: A Case Study in Anti-infectivesC Daniel Mullins, Frank R Ernst, Michelle R Krukas, et al.
American Journal of Surgery|February 3, 2009
Fournier's gangrene: vacuum-assisted closure versus conventional dressingsRalf Czymek, Andreas Schmidt, Christian Eckmann, et al.
Deutsche Medizinische Wochenschrift (1946)|June 27, 2015
[Current strategies against multi-drug resistant organisms]Mathias W Pletz, Christian Eckmann, Stefan Hagel, et al.
European Journal of Internal Medicine|July 30, 2024
Intra-abdominal infection and sepsis in immunocompromised intensive care unit patients: Disease expression, microbial aetiology, and clinical outcomesJosé-Artur Paiva, Jordi Rello, Christian Eckmann, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 12, 2015
Ceftolozane/Tazobactam Plus Metronidazole for Complicated Intra-abdominal Infections in an Era of Multidrug Resistance: Results From a Randomized, Double-Blind, Phase 3 Trial (ASPECT-cIAI)Joseph Solomkin, Ellie Hershberger, Benjamin Miller, et al.
Plos One|December 28, 2022
Clinical and economic burden of surgical site infections in inpatient care in Germany: A retrospective, cross-sectional analysis from 79 hospitalsChristian Eckmann, Axel Kramer, Ojan Assadian, et al.
Pageof 8